Статті в журналах з теми "Modified progressive profiling"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Modified progressive profiling".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Kang, Wenyu, Jun Niimi, Richard A. Muhlack, Paul A. Smith, and Susan E. P. Bastian. "Dynamic characterization of wine astringency profiles using modified progressive profiling." Food Research International 120 (June 2019): 244–54. http://dx.doi.org/10.1016/j.foodres.2019.02.041.
Повний текст джерелаBoekhoff, Henning, Laura Hendricks, Elena Cairo, Andrea Bauer, Mari Hambardzumyan, Markus W. Büchler, Silvia Calderazzo, et al. "Abstract A035: Profiling of circulating autoreactive antibodies in some 1200 patients with pancreatic ductal adenocarcinoma and progressive precursor lesions." Cancer Research 82, no. 22_Supplement (November 15, 2022): A035. http://dx.doi.org/10.1158/1538-7445.panca22-a035.
Повний текст джерелаManzi, Vincenzo, Carlo Castagna, Elvira Padua, Mauro Lombardo, Stefano D'Ottavio, Michele Massaro, Maurizio Volterrani, and Ferdinando Iellamo. "Dose-response relationship of autonomic nervous system responses to individualized training impulse in marathon runners." American Journal of Physiology-Heart and Circulatory Physiology 296, no. 6 (June 2009): H1733—H1740. http://dx.doi.org/10.1152/ajpheart.00054.2009.
Повний текст джерелаWang, Xuehai, Deanne Gracias, Michael Nissen, Elizabeth Chavez, Gabriela Cristina Segat, Manabu Kusakabe, Guillermo Simkin, et al. "Single-Cell Profiling Reveals Distinct Tumor Subtypes and Their Associated T-Cell Environments in Follicular Lymphoma." Blood 132, Supplement 1 (November 29, 2018): 1577. http://dx.doi.org/10.1182/blood-2018-99-114182.
Повний текст джерелаGupta, Sameer, Jeetendra Paryani, Arun Chaturvedi, Vijay Kumar, and Naseem Akhtar. "Triple negative breast cancer: An Indian problem— Experience from a tertiary care oncology centre." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): e12583-e12583. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12583.
Повний текст джерелаFurini, Giulia, Nina Schroeder, Linghong Huang, David Boocock, Alessandra Scarpellini, Clare Coveney, Elisa Tonoli, et al. "Proteomic Profiling Reveals the Transglutaminase-2 Externalization Pathway in Kidneys after Unilateral Ureteric Obstruction." Journal of the American Society of Nephrology 29, no. 3 (January 30, 2018): 880–905. http://dx.doi.org/10.1681/asn.2017050479.
Повний текст джерелаViteri, Santiago, Werner Hilgers, Fabrice Denis, Elisabeth Quoix, Gilles Robinet, Enriqueta Felip, Rafal Dziadziuszko, et al. "366 Combined exploratory immunophenotyping and transcriptomic tumor analysis in patients treated with OSE2101 vaccine in HLA-A2+ advanced non-small cell lung cancer (NSCLC) from the ATALANTE-1 trial." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A394. http://dx.doi.org/10.1136/jitc-2021-sitc2021.366.
Повний текст джерелаGacita, Anthony M., Dominic E. Fullenkamp, Joyce Ohiri, Tess Pottinger, Megan J. Puckelwartz, Marcelo A. Nobrega, and Elizabeth M. McNally. "Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression." Circulation 143, no. 13 (March 30, 2021): 1302–16. http://dx.doi.org/10.1161/circulationaha.120.050432.
Повний текст джерелаKim, Hyun Kyu, Su Young Son, Jae Sang Oh, Ye Na Song, Ja Min Byun, Youngil Koh, Junshik Hong, et al. "Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples." Metabolites 11, no. 9 (August 31, 2021): 586. http://dx.doi.org/10.3390/metabo11090586.
Повний текст джерелаMunshi, Nikhil C., Cheng Li, Stephane Minvielle, Samir B. Amin, Philippe Moreau, Florence Magrangeas, Kenneth C. Anderson, and Herve Avet-Loiseau. "Expression Profile Signature to Predict Response to Bortezomib and Dexamethasone Combination Therapy in Newly-Diagnosed Myeloma: Moving towards Prospective Prediction." Blood 112, no. 11 (November 16, 2008): 2746. http://dx.doi.org/10.1182/blood.v112.11.2746.2746.
Повний текст джерелаAvena, Paola, Arianna De Luca, Adele Chimento, Marta Claudia Nocito, Sara Sculco, Davide La Padula, Lucia Zavaglia та ін. "Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression". Cancers 14, № 16 (11 серпня 2022): 3885. http://dx.doi.org/10.3390/cancers14163885.
Повний текст джерелаTorres-Collado, Antoni X., Ramin Nazarian, and Ali R. Jazirehi. "Rescue of cell cycle progression in BRAFV600E inhibitor–resistant human melanoma by a chromatin modifier." Tumor Biology 39, no. 9 (September 2017): 101042831772162. http://dx.doi.org/10.1177/1010428317721620.
Повний текст джерелаReiss, David J., Trevor Do, David Kuo, Vanessa E. Gray, N. Eric Olson, Chung-Wein Lee, Mary H. Young, et al. "Multiplexed Immunofluorescence (IF) Analysis and Gene Expression Profiling of Biopsies from Patients with Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL) Treated with Lisocabtagene Maraleucel (liso-cel) in Transcend NHL 001 Reveal Patterns of Immune Infiltration Associated with Durable Response." Blood 134, Supplement_1 (November 13, 2019): 202. http://dx.doi.org/10.1182/blood-2019-127683.
Повний текст джерелаGermanguz, Igal, Jenny C. Park, Jessica Cinkornpumin, Aryeh Solomon, Minori Ohashi, and William E. Lowry. "TDG regulates cell cycle progression in human neural progenitors." F1000Research 7 (April 26, 2018): 497. http://dx.doi.org/10.12688/f1000research.13801.1.
Повний текст джерелаKelly, Lori A., Ali H. Zaidi, Mark Barlek, Rachael Kreft, Ashten Omstead, Juliann Kosovec, Yoshihiro Komatsu, and Blair A. Jobe. "Role of microbiota and Toll-like receptors in progression of esophageal adenocarcinoma (EAC) in a rat reflux model." Journal of Clinical Oncology 33, no. 3_suppl (January 20, 2015): 28. http://dx.doi.org/10.1200/jco.2015.33.3_suppl.28.
Повний текст джерелаGaipov, Abduzhappar, Zhalaliddin Makhammajanov, Zhanna Dauyey, Zhannur Markhametova, Kamilla Mussina, Assem Nogaibayeva, Larissa Kozina, et al. "Urinary Protein Profiling for Potential Biomarkers of Chronic Kidney Disease: A Pilot Study." Diagnostics 12, no. 11 (October 25, 2022): 2583. http://dx.doi.org/10.3390/diagnostics12112583.
Повний текст джерелаVieira, Filipa Quintela, Pedro Costa-Pinheiro, João Ramalho-Carvalho, Andreia Pereira, Francisco Duarte Menezes, Luís Antunes, Isa Carneiro, Jorge Oliveira, Rui Henrique, and Carmen Jerónimo. "Deregulated expression of selected histone methylases and demethylases in prostate carcinoma." Endocrine-Related Cancer 21, no. 1 (November 7, 2013): 51–61. http://dx.doi.org/10.1530/erc-13-0375.
Повний текст джерелаLisberg, Aaron Elliott, Bin Liu, Ramin Salehi-Rad, Jay M. Lee, Linh Tran, Kostyantyn Krysan, Raymond Lim, et al. "Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): TPS9135. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps9135.
Повний текст джерелаSweeney, Jenna Geddes, Jennifer Liang, Nicholas Giovannone, Lana Schaffer, Steven R. Head, Aristotelis Antonopoulos, Stuart M. Haslam, Hans R. Widlund, and Charles J. Dimitroff. "“I”-branched Carbohydrates Negatively Regulate Galectin-3-binding and Melanoma Malignancy." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 144.17. http://dx.doi.org/10.4049/jimmunol.196.supp.144.17.
Повний текст джерелаTabolacci, Claudio, Martina Cordella, Sabrina Mariotti, Stefania Rossi, Cinzia Senatore, Carla Lintas, Lauretta Levati, et al. "Melanoma Cell Resistance to Vemurafenib Modifies Inter-Cellular Communication Signals." Biomedicines 9, no. 1 (January 15, 2021): 79. http://dx.doi.org/10.3390/biomedicines9010079.
Повний текст джерелаPilon, Andre M., Murat O. Arcasoy, Holly K. Dressman, Serena E. Vayda, Yelena D. Maksimova, Jose I. Sangerman, Patrick G. Gallagher, and David M. Bodine. "Failure of Terminal Erythroid Differentiation in EKLF-Deficient Mice Is Associated with Cell Cycle Perturbation and Reduced Expression of E2F2." Molecular and Cellular Biology 28, no. 24 (October 13, 2008): 7394–401. http://dx.doi.org/10.1128/mcb.01087-08.
Повний текст джерелаXie, Wensheng, Robert S. Ames, and Hu Li. "A Cell-Based High-Throughput Screening Assay to Measure Cellular Histone H3 Lys27 Trimethylation with a Modified Dissociation-Enhanced Lanthanide Fluorescent Immunoassay." Journal of Biomolecular Screening 17, no. 1 (November 15, 2011): 99–107. http://dx.doi.org/10.1177/1087057111422378.
Повний текст джерелаZhang, Wei, Jinke Sui, Xianrui Wu, Fuao Cao, Guanyu Yu, Chenyang Wang, Zhihong Zhang, et al. "DNA methylation profiling from circulating tumor DNA for early-detection of colorectal cancer." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e15076-e15076. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15076.
Повний текст джерелаLee, Choong-kun, Jaekyung Cheon, Hong Jae Chon, Min Hwan Kim, Jin Won Kim, Myung Ah Lee, Hyung Soon Park, Myoung Joo Kang, Joung-Soon Jang, and Hye Jin Choi. "A phase II trial of trastuzumab plus modified-FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer (BTC): Multi-institutional study of the Korean Cancer Study Group (KCSG-HB19-14)." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): TPS4161. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps4161.
Повний текст джерелаCattrini, Carlo, Marcello Manfredi, Paola Barboro, Marco Ghirimoldi, Alessia Mennitto, Veronica Martini, Federica Biello, et al. "Lipidomic profiling in patients with heavily pretreated castration-resistant prostate cancer." Journal of Clinical Oncology 40, no. 6_suppl (February 20, 2022): 174. http://dx.doi.org/10.1200/jco.2022.40.6_suppl.174.
Повний текст джерелаCzuczman, Myron S., Andrew Davies, Kim M. Linton, Nina Wagner-Johnston, Randy D. Gascoyne, David A. Eberhard, Gilles Salles, et al. "A Phase 2/3 Multicenter, Randomized Study Comparing the Efficacy and Safety of Lenalidomide Versus Investigator’s Choice in Relapsed/Refractory DLBCL." Blood 124, no. 21 (December 6, 2014): 628. http://dx.doi.org/10.1182/blood.v124.21.628.628.
Повний текст джерелаGraham, Trevor A. "Abstract IA024: The role of the epigenome and phenotypic plasticity in colorectal cancer evolution." Cancer Research 82, no. 10_Supplement (May 15, 2022): IA024. http://dx.doi.org/10.1158/1538-7445.evodyn22-ia024.
Повний текст джерелаSilk, Ann W., Nicole R. LeBoeuf, Guilherme Rabinowits, Igor Puzanov, Melissa Amber Burgess, Sumana Devata, Dirk Moore, et al. "A phase II study of talimogene laherparepvec followed by talimogene laherparepvec + nivolumab in refractory T cell and NK cell lymphomas, cutaneous squamous cell carcinoma, Merkel cell carcinoma, and other rare skin tumors (NCI #10057)." Journal of Clinical Oncology 36, no. 5_suppl (February 10, 2018): TPS219. http://dx.doi.org/10.1200/jco.2018.36.5_suppl.tps219.
Повний текст джерелаEpelbaum, Ron, Einat Shacham-Shmueli, Ravit Geva, and Ayala Hubert. "Molecular profiling (MP)-selected therapy for the treatment of patients with advanced pancreaticobiliary cancer (PBC)." Journal of Clinical Oncology 31, no. 4_suppl (February 1, 2013): 195. http://dx.doi.org/10.1200/jco.2013.31.4_suppl.195.
Повний текст джерелаHan, P., C. Hou, X. Zheng, L. Cao, X. Shi, X. Zhang, H. Ye, T. Li, F. Hu, and Z. Li. "AB0058 SERUM ANTIGENOME PROFILING REVEALS DIAGNOSTIC MODELS FOR RHEUMATOID ARTHRITIS." Annals of the Rheumatic Diseases 81, Suppl 1 (May 23, 2022): 1162.2–1163. http://dx.doi.org/10.1136/annrheumdis-2022-eular.613.
Повний текст джерелаPhillipou, Alexander N., Charles S. Lay, Charlotte E. Carver, Cassie Messenger, John P. Evans, Antonia J. Lewis, Laurie J. Gordon, et al. "Cellular Target Engagement Approaches to Monitor Epigenetic Reader Domain Interactions." SLAS DISCOVERY: Advancing the Science of Drug Discovery 25, no. 2 (December 25, 2019): 163–75. http://dx.doi.org/10.1177/2472555219896278.
Повний текст джерелаRichard, Corentin, Myriam Benlaifaoui, Omar El Ouarzadi, Khoudia Diop, Antoine Desilets, Julie Malo, Wiam Belkaid, et al. "679 High fiber diet modifies gut microbiome, propionate production, intratumor immune response and is associated with outcome in patients with lung cancer treated with immune checkpoint inhibitors." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A718. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0679.
Повний текст джерелаPapanikolaou, Xenofon, Adam Rosenthal, Rashid Z. Khan, Joshua Epstein, Christoph Heuck, Madhav V. Dhodapkar, Yogesh Jethava, et al. "Flow Cytometry Defined Cytoplasmic Immunoglobulin Index Is a Major Prognostic Factor for Progression of Asymptomatic Monoclonal Gammopathies to Clinical Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 2079. http://dx.doi.org/10.1182/blood.v124.21.2079.2079.
Повний текст джерелаLiu, Caifei, Yingxin Shi, Jie Li, Xuewen Liu, Zhikai Xiahou, Zhongping Tan, Xing Chen, and Jing Li. "O-GlcNAcylation of myosin phosphatase targeting subunit 1 (MYPT1) dictates timely disjunction of centrosomes." Journal of Biological Chemistry 295, no. 21 (April 15, 2020): 7341–49. http://dx.doi.org/10.1074/jbc.ra119.012401.
Повний текст джерелаZhao, Z. "TET2 Loss Dysregulates the Behavior of Mesenchymal Stem Cells and Increases Their Ability to Promote TET2−/−-Driven Myeloid Malignancy Progression." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 222s. http://dx.doi.org/10.1200/jgo.18.90100.
Повний текст джерелаYang, Jung-In, Taehoon Ha, Edward Zhou, Chris Tzanavaris, Craig E. Devoe, Xinhua Zhu, and Jeff Boyd. "Association of TP53 mutation status and GATA6 amplification with clinical outcome of pancreatic cancer." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e16224-e16224. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e16224.
Повний текст джерелаDicitore, Alessandra, Maria Giulia Bacalini, Davide Saronni, Germano Gaudenzi, Maria Celeste Cantone, Giulia Gelmini, Elisa Stellaria Grassi, et al. "Role of Epigenetic Therapy in the Modulation of Tumor Growth and Migration in Human Castration-Resistant Prostate Cancer Cells with Neuroendocrine Differentiation." Neuroendocrinology 112, no. 6 (August 2, 2021): 580–94. http://dx.doi.org/10.1159/000518801.
Повний текст джерелаWang, Juan, Haixia Guo, Cai Yun, Huiqin Chen, Liangchun Yang, Huihong Dou, Xin Tian, et al. "The Profiling of Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma(B-NHL): A Multicenter and Prospective Clinical Study." Blood 138, Supplement 1 (November 5, 2021): 2400. http://dx.doi.org/10.1182/blood-2021-151686.
Повний текст джерелаDemaree, Benjamin, Cyrille Delley, Cheryl Peretz, Harish Vasudevan, David Ruff, Aik Ooi, Catherine C. Smith, and Adam Abate. "Combined Single-Cell DNA Genotyping and Protein Quantification (DAb-seq) in Acute Myeloid Leukemias Reveals Distinct Immunophenotypic Subsets Among Pathogenic Clones." Blood 134, Supplement_1 (November 13, 2019): 2088. http://dx.doi.org/10.1182/blood-2019-127048.
Повний текст джерелаHerrera, Alex F., Samuel Tracy, Brandon Croft, Stephen Opat, Jill Ray, Lisa Musick, Joseph N. Paulson, Laurie H. Sehn, and Yanwen Jiang. "Risk Profiling of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients By Measuring Circulating Tumor DNA." Blood 136, Supplement 1 (November 5, 2020): 23–25. http://dx.doi.org/10.1182/blood-2020-136645.
Повний текст джерелаLiu, Bin, Aaron Lisberg, Ramin Salehi-Rad, Jay Lee, Linh M. Tran, Kostyantyn Krysan, Raymond Lim, et al. "Abstract CT219: Phase I trial of in situ vaccination with autologous CCL21 gene-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced non-small cell lung cancer (NSCLC)." Cancer Research 82, no. 12_Supplement (June 15, 2022): CT219. http://dx.doi.org/10.1158/1538-7445.am2022-ct219.
Повний текст джерелаJohann, Donald, Pingping Qu, Rachael Sexton, Antje Hoering, Joshua Epstein, Shmuel Yaccoby, Frits van Rhee, Saad Z. Usmani, John Crowley, and Bart Barlogie. "Gene Expression Profiling (GEP) of Whole Bone Marrow Biopsies (BMB) in Multiple Myeloma (MM) – Relationship to Plasma-Cell (PC)-Based GEP-Defined Risk and Molecular Subgroups." Blood 120, no. 21 (November 16, 2012): 3953. http://dx.doi.org/10.1182/blood.v120.21.3953.3953.
Повний текст джерелаHo, Christine M., Theresa Hahn, Paul K. Wallace, Yali Zhang, Ahmad Fora, George L. Chen, Sarah A. Holstein, et al. "Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation." Blood 128, no. 22 (December 2, 2016): 3454. http://dx.doi.org/10.1182/blood.v128.22.3454.3454.
Повний текст джерелаSanchez-Guijo, Fermin M., Eva Lumbreras, Patricia Morais, Juan-Luis Garcia, Norma C. Gutierrez, J. F. San Miguel, Consuelo del Canizo, and Jesus M. Hernandez-Rivas. "Imatinib Mesilate Modifies Genes Involved in Hematopoiesis in Non Clonal Bone Marrow Cells from CML Patients in Complete Cytogenetic Response." Blood 110, no. 11 (November 16, 2007): 2947. http://dx.doi.org/10.1182/blood.v110.11.2947.2947.
Повний текст джерелаKhan, Uqba, Talia Biran, Allyson J. Ocean, Elizabeta C. Popa, Joseph T. Ruggiero, Doru Paul, Chelsea Garcia, et al. "Phase II study of a telomerase-specific oncolytic adenovirus (OBP-301, Telomelysin) in combination with pembrolizumab in gastric and gastroesophageal junction adenocarcinoma." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): TPS4145. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps4145.
Повний текст джерелаPapaioannou, Dimitrios, Andreas Petri, Charlotte Albæk Thrue, Stefano Volinia, Karl Kroll, Yan Pearlly, Ralf Bundschuh, et al. "HOXB-AS3 Regulates Cell Cycle Progression and Interacts with the Drosophila Splicing Human Behavior (DSHB) Complex in NPM1-Mutated Acute Myeloid Leukemia." Blood 128, no. 22 (December 2, 2016): 1514. http://dx.doi.org/10.1182/blood.v128.22.1514.1514.
Повний текст джерелаde Souza, J. A., C. Wei, S. Noguchi, K. Lu, H. Ishihara, D. Aoki, and N. T. Ueno. "Cyclin-dependent kinase (CDK) activity as a prognostic marker in primary epithelial ovarian cancer." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 5575. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.5575.
Повний текст джерелаFong, Jerry, John R. Edwards, Jacob R. Gardner, Amanda F. Cashen, Kilian Q. Weinberger, and Jacqueline E. Payton. "A Novel Method to Identify Epigenetic Subclones with Increased Fitness from Genomic DNA Methylation Data of Lymphoma and Leukemia Patients." Blood 132, Supplement 1 (November 29, 2018): 2604. http://dx.doi.org/10.1182/blood-2018-99-111057.
Повний текст джерелаVaid, Ashok K., Suman S. Karanth, Aseem Khurana, Nitin Sood, Ashok Sen, Gautam Dheeraj, Bhuvan Chugh, and Saurabh Mishra. "Differences in the Clinicopathological Feature, Prognostic Features and Treatment Outcomes between Molecular Subtypes Among Indian Cohort with Diffuse Large B-Cell Lymphoma - a Single Center Experience." Blood 134, Supplement_1 (November 13, 2019): 5350. http://dx.doi.org/10.1182/blood-2019-126414.
Повний текст джерелаAvigdor, Abraham, Pierre Peterlin, Junichiro Yuda, Mor Tal Moskovitz, Nashat Y. Gabrail, Yakir Moshe, Bruno Quesnel, et al. "Phase 1 first-in-human study of ABBV-184 monotherapy in adult patients with previously treated acute myeloid leukemia or non-small cell lung cancer." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): TPS2674. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps2674.
Повний текст джерела